Clinical Trials Sponsored by Quigley Pharma, Inc.
Total 2360 results
-
Astellas Pharma IncTerminatedComparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICUInvasive Fungal InfectionsUnited States, Canada
-
ZARS Pharma Inc.CompletedHand DermatosesUnited States
-
Astellas Pharma IncCompletedThromboembolismSingapore, Indonesia, Japan, Korea, Republic of, Malaysia, Philippines, Taiwan, Thailand
-
Akros Pharma Inc.Completed
-
Akros Pharma Inc.Terminated
-
Astellas Pharma IncCompletedGastroesophageal RefluxJapan
-
Astellas Pharma IncCompletedCoronary Artery Disease | HypercholesteremiaJapan
-
Astellas Pharma IncCompletedHealthy Subjects | Drug Interactions | Pharmacokinetics of ASP015KUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamic and Pharmacokinetic InteractionFrance
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin SuccinateUnited States
-
Astellas Pharma IncCompletedKidney TransplantationUnited States
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of ASP015KUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamics | Pharmacokinetics of ASP015KUnited States
-
Artisan Pharma, Inc.CompletedSepsis | Disseminated Intravascular CoagulationUnited States, Canada, Thailand, Malaysia
-
Astellas Pharma IncCompleted
-
UMN Pharma Inc.Completed
-
Astellas Pharma IncCompletedAtrial FibrillationGermany, Korea, Republic of, Australia, Poland, United Kingdom, Japan, South Africa, Russian Federation, Austria, Estonia, Thailand, Bulgaria, France, Spain, Ukraine, India, Israel, Hungary, Slovakia, Malaysia, Philippines, Czech... and more
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of AtorvastatinJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of EnalaprilJapan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Akela Pharma, Inc.Unknown
-
Akros Pharma Inc.Completed
-
Akros Pharma Inc.CompletedType II HyperlipidemiaNetherlands
-
Akros Pharma Inc.Completed
-
Astellas Pharma IncCompletedLiver TransplantationUnited Kingdom, Germany, Spain, Belgium, Switzerland, Canada, Netherlands, Czech Republic, France, Hungary, Austria, Italy
-
Astellas Pharma IncCompletedKeratoconjunctivitis | ConjunctivitisJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma Global Development, Inc.Not yet recruitingClaudin 18.2 (CLDN18.2) Positive Metastatic Pancreatic Adenocarcinoma
-
Astellas Pharma Global Development, Inc.RecruitingNeurogenic Detrusor OveractivityPhilippines, Turkey, Belgium, Denmark
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | FLT3-mutated Acute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)United States, Canada, Germany, Italy, Spain, United Kingdom, France
-
Astellas Pharma Global Development, Inc.Active, not recruitingAdvanced Cancer | Advanced MalignanciesUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingStargardt's Macular DystrophyItaly, United States, Israel, United Kingdom, Germany, Spain, Hungary, France
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingAge-Related Macular Degeneration | Geographic AtrophyUnited States, Italy, Latvia, France, Israel, Germany, Spain, Hungary, Brazil, Canada, Argentina, Colombia, Croatia, Australia, Austria, Belgium, Czechia
-
Astellas Pharma Global Development, Inc.CompletedInvasive Aspergillosis | Invasive MucormycosisUnited States, Belgium, Spain
-
Astellas Pharma Global Development, Inc.TerminatedReduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen ExtractionUnited States
-
Astellas Pharma Global Development, Inc.CompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML)United States, Japan
-
Astellas Pharma Global Development, Inc.CompletedHot FlashesUnited States, Canada, Czechia, Hungary, Poland, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedRenal Impairment | Healthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid LeukemiaUnited States